|
|
| Line 1: |
Line 1: |
| [[Image:1xn3.gif|left|200px]] | | {{Seed}} |
| | [[Image:1xn3.png|left|200px]] |
|
| |
|
| <!-- | | <!-- |
| Line 9: |
Line 10: |
| {{STRUCTURE_1xn3| PDB=1xn3 | SCENE= }} | | {{STRUCTURE_1xn3| PDB=1xn3 | SCENE= }} |
|
| |
|
| '''Crystal structure of Beta-secretase bound to a long inhibitor with additional upstream residues.'''
| | ===Crystal structure of Beta-secretase bound to a long inhibitor with additional upstream residues.=== |
|
| |
|
|
| |
|
| ==Overview==
| | <!-- |
| Memapsin 2 (beta-secretase) is the membrane-anchored aspartic protease that initiates the cleavage of beta-amyloid precursor protein (APP), leading to the production of amyloid-beta (Abeta), a major factor in the pathogenesis of Alzheimer's disease. The active site of memapsin 2 has been shown, with kinetic data and crystal structures, to bind to eight substrate residues (P(4)-P(4)'). We describe here that the addition of three substrate residues from P(7) to P(5) strongly influences the hydrolytic activity by memapsin 2 and these subsites prefer hydrophobic residues, especially tryptophan. A crystal structure of memapsin 2 complexed with a statine-based inhibitor spanning P(10)-P(4)' revealed the binding positions of P(5)-P(7) residues. Kinetic studies revealed that the addition of these substrate residues contributes to the decrease in K(m) and increase in k(cat) values, suggesting that these residues contribute to both substrate recognition and transition-state binding. The crystal structure of a new inhibitor, OM03-4 (K(i) = 0.03 nM), bound to memapsin 2 revealed the interaction of a tryptophan with the S(6) subsite of the protease.
| | The line below this paragraph, {{ABSTRACT_PUBMED_15628850}}, adds the Publication Abstract to the page |
| | (as it appears on PubMed at http://www.pubmed.gov), where 15628850 is the PubMed ID number. |
| | --> |
| | {{ABSTRACT_PUBMED_15628850}} |
|
| |
|
| ==About this Structure== | | ==About this Structure== |
| Line 35: |
Line 39: |
| [[Category: Drug design]] | | [[Category: Drug design]] |
| [[Category: Memapsin2]] | | [[Category: Memapsin2]] |
| ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 15:14:57 2008'' | | |
| | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 12:56:14 2008'' |